Iradimed (IRMD) news
Recent news
Iradimed Q2 adjusted EPS USD 0.46
AInvest Wire · Jul 31, 2026Iradimed Corp: Continue to gain efficiencies, which we expect will be reflected in a higher gross margin in second half of year
AInvest Wire · Jul 31, 2026Iradimed Corp - reaffirms FY2026 revenue guidance $91 mln-$96 mln, non-GAAP diluted EPS $2.09-$2.24
AInvest Wire · Jul 31, 2026Iradimed Q2 EPS USD 0.41
Iradimed Corporation (NASDAQ: IRMD) reported second-quarter 2026 earnings per share (EPS) of $0.41, reflecting continued growth in its MRI-compatible medical device business. The company, which specializes in non-magnetic intravenous infusion pumps and patient monitoring systems for use during MRI…
AInvest Wire · Jul 31, 2026Iradimed Q2 revenue USD 20.5 million
IRADIMED CORPORATION reported revenue of $20.5 million for the second quarter of 2025, reflecting a 14% increase compared to the same period in 2024. This marks the company’s sixteenth consecutive quarter of record revenue, underscoring sustained demand for its MRI-compatible medical devices. The…
AInvest Wire · Jul 31, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.